The global threat of the Zika virus to humanity is real. Innovative and potent antiZika virus drugs are still at large, due to the lack of anti-Zika virus drugs that have passed phase 1 trials. Experimental research has revealed novel inhibitors of Zika virus NS5 methyltransferase enzyme. This study has taken a step further to provide insight into the molecular dynamics of Zika virus and inhibitor binding, which have not been established experimentally. Movements of the methyltransferase binding site loops have a large role to play in the methylation of the viral mRNA cap, which is essential for Zika virus replication. Here, we pinpoint the binding interactions between each potential inhibitor and the methyltransferase, residues that are responsible for binding, as well as which inhibitor-bound complex renders the methyltransferase more stable. We also highlight the conformational changes that occur within the methyltransferase to accommodate binding of inhibitors and consequences of those changes upon the RNA-and cap-binding sites in the methyltransferase. This research will improve the understanding of the Zika virus NS5 methyltransferase enzyme, and will be beneficial in driving the development of anti-Zika virus drugs.
| INTRODUCTION
In the beginning of 2016, the World Health Organization declared the escalating Zika virus (ZIKV) a public health crisis due to its association with neonatal microcephaly and Guillain-Barré syndrome. [1] ZIKV, the rapidly disseminating pathogen, which belongs to the flavivirus genus of the Flaviviridae family, is related to other flaviviruses, including West Nile virus (WNV), Yellow fever virus (YFV), Japanese encephalitis virus (JEV), and Dengue virus (DENV). [2] ZIKV has revealed a tropism for a broad range of tissues including sensory organs and organs of the gastrointestinal tract, respiratory system, and reproductive system. [3] [4] [5] [6] The preeminent mode of transmission of ZIKV is through the bite of a previously infected Aedes aegypti mosquito, which acts as a viral vector. ZIKV may also be distributed via sexual intercourse, blood transfusion, maternal transmission, and physical contact. [7] Control measures have been put in place to curb the spread of the virus, however, ultimate success is yet to be attained. [8] Vaccine development is still several years away since vaccine candidates are still in preclinical trials. [9] Additionally, due to the erratic and spontaneous temperament of flavivirus outbreaks, vaccine development against flaviviruses is restricted. [10] As a result of the extensive period involved in establishing a ZIKV vaccine, there are current endeavors toward developing antiviral therapeutics. [11] To date, flavivirus infections prevail with no approved antiviral treatment. Present-day treatment of ZIKV is based on the symptoms of infection. [12] There is also the question of whether or not novel inhibitors will pass the blood-brain barrier. [13] Generally, research is turned toward drugs that inhibit enzymes involved in critical steps in the life cycle of the virus. [14] [15] [16] There has been a compelling amount of research in the last 10 years, which had been directed toward the establishment of inhibitors of targeted enzymes of other flaviviruses including DENV, WNV, and YFV. [17, 18] There may be no elixir for treating ZIKV, but recognizing the targets that provide optimal therapy will aid science in establishing the most effective therapeutics. The flavivirus NS5 methyltransferase (MTase) enzyme is an attractive target for the development of inhibitors due to its fundamental roles in viral replication via formation of the viral mRNA cap as well as modulation of immune response. [16] We illustrate in Figure 1 , the ZIKV NS5 MTase responsible for methylation of the viral mRNA cap, as well as the RNA-dependent RNApolymerase (RdRp) responsible for viral RNA replication. [17] Together, these subunits work in harmony to ensure viral replication. [19] By virtue of the resemblance between flaviviruses, particularly between DENV and ZIKV, as we have presented in Figure 2 , a great deal of the information regarding the drug discovery of DENV may possibly be enforced toward the establishment of ZIKV inhibitors. [7, 20] Inhibitors that have been shown to suppress the MTase of DENV have also been potent in the inhibition of ZIKV MTase. [14, 21, 22] A profoundly essential molecule for both DENV and ZIKV replication, particularly regarding the MTase component, includes S-adenosyl-L-methionine (SAM). [21] Being the natural substrate of the MTase, SAM serves as a methyl donor and allows for methylation of the mRNA cap, which is imperative for viral replication. [23] We demonstrate in Figure 3 , that an absence of SAM-binding, as a result of displacement by an alternative compound, causes avoidance of viral replication since methylation of RNA does not occur. The adenosine derivative, sinefungin (SFG), was initially isolated as an antifungal antibiotic from Streptomyces griseolus, and accomplishes its inhibition by competitively binding to the SAM-binding pocket in the MTase. [24] Previously, SFG demonstrated inhibitory effects on MTases of DENV, WNV, and YFV, [17] and thus presented as a potential inhibitor of ZIKV. [25] Experimental evidence shows that even low concentrations of SFG inhibit ZIKV MTase and terminates internal methylation in vitro. [21] Coutard et al. in 2017 also demonstrations ZIKV suppression by another DENV inhibitor, Compound 5, which inhibits ZIKV MTase activity and is more potent against ZIKV MTase compared to MTases of DENV and WNV. [14, 21, 22] In Figure 4 , we illustrate the structures of SFG and Compound 5. Based on preliminary viral inhibition and structural novelty, we considered further exploring the structural dynamics that take place at a molecular level within the independent ZIKV MTase (Apo), as well as ZIKV MTase bound to SFG and Compound 5, distinctly. We also compare the binding affinity, binding mode and stability of the bound complex of SFG to that of Compound 5. Two major loops in the MTase were focused on more than the rest, as one of the loops surrounds the SAM-binding pocket and the other surround the RNA-binding site. To our knowledge, this is the first study that utilizes integrated computational methods to analyze how binding of inhibitors, SFG and Compound 5, impact the conformational changes that occur within the ZIKV NS5 MTase. Furthermore, we speculate that this study will improve the understanding of the structural information of the inhibitors and the ZIKV NS5 MTase, and will be valuable in anti-ZIKV drug design. 
| System preparation
The crystal structure of the NS5 MTase of ZIKV in complex with SFG was accessed from RCSB Protein Data Bank (PDB code: 5MRK). [25] The protein (MTase) and ligands (SFG and Compound 5) were prepared using Molegro Molecular Viewer software (Molegro-a CLC bio company, Aarhus, Denmark) and UCSF Chimera software package. [12] The crystal structure of the MTase protein consists of chains A and B, however, in order to save computational time and expense, the distinct ligands conjugated to the singular chain A was utilized. Compound 5 was modeled using Avodagro. [26] Three systems including the Apo MTase, SFG-bound MTase and Compound 5-bound MTase were subjected to a 200 ns molecular dynamic simulation (described in Section 2.3).
| Molecular docking
Molecular docking was used to predict optimized conformations and binding affinities of SFG and Compound 5 within the SAM-binding pocket of ZIKV NS5 MTase. [27] Docking software that was used in this study includes UCSF Chimera [12, 27] and AutoDock Vina. [28] SFG and Compound 5 were docked into the SAM-binding pocket of the NS5 MTase (grid box spacing of 0.375 Å and x, y, z dimensions of 28 × 32 × 34). The complex with the most negative binding energy (kcal/mol) was subjected to molecular dynamic simulations. A greater expansion of molecular docking can be found in the referenced articles. [29] [30] [31] 
| Molecular dynamic simulation
Molecular dynamic simulations were implemented using AMBER PMEMD dynamics engine with GPU acceleration and the protein was parameterized with the AMBER force field, FF14SB. [32] [33] [34] [35] Hydrogen atoms were removed from the MTase protein, while SFG and Compound 5 were hydrogenated and charged with Gasteiger charges preceding the simulation. Antechamber created atomic partial charges for SFG and Compound 5 using the general AMBER force field (GAFF) and restrained electrostatic potential (RESP) methods. [36] [37] [38] The LEAP module implemented in AMBER 14 was used to combine, neutralize, and solvate the systems by adding hydrogen atoms, chloride and sodium ions and suspending them in an orthorhombic box of TIP3P water molecules such that all atoms were within 10 Å of the box edges.
The amino acid residues of the protein were renumbered due to missing residues in the initial crystal structure; therefore, all residue numbers reported from these findings are in fact four residues less than stated. An initial energy minimization of 2,500 steps was performed with a restraint potential of 10 kcal mol −1 Å −2 applied to the solutes, for 1,000 steps of steepest descent followed by 1,000 steps of conjugate gradient minimization. An additional unrestrained full minimization of 200 steps was performed by conjugate gradient algorithm. A canonical ensemble (NVT) simulation was carried out for 50 ps from 0 to 300 K, so that a fixed volume and number of atoms in each system was maintained. The systems' solutes were enforced with Langevin thermostat collision frequency of 1.0 ps −1 and a potential harmonic restraint of
. Thereafter, each system was equilibrated for 500 ps with a constant operating temperature of 300 K, as well as a constant pressure of 1 bar using the Berendsen barostat and number of atoms resembling an isobaric-isothermal ensemble. The overall simulation was conducted for 200 ns, where each simulation incorporated the shake algorithm to restrain hydrogen bonds. An SPFP precision model was utilized.
| Postdynamic analysis

| Computation of thermodynamic binding free energy and per-residue decomposition analysis
A well-known method utilized to determine the binding free energy (ΔG bind ) of small ligands to biological macromolecules includes molecular mechanics incorporated with the Poisson-Boltzmann or generalized Born and surface area continuum solvation (MM/PBSA and MM/GBSA) approach. [39] These methods are generally established on molecular dynamics simulations of the protein-ligand complex and are thus transitional in precision between empirical scoring and strict enzymatic perturbation methods. [40] ΔG bind was averaged over 50,000 snapshots derived from the 200 ns trajectory. The binding strength estimated using this method for the MTase, SFG-and Compound 5-complexes could be represented as:
where E ele , Electrostatic potential energy from Coulomb forces; E gas , Gas-phase energy (based on FF14SB force field terms); E int , Internal energy; E vdW , van der Waals energy; G sol , Solvation free energy; G GB , Polar solvation energy; G SA , non-polar solvation energy; S, Total entropy of solute; SASA, Solvent accessible surface area (water probe radius of 1.4 Å). T, Total entropy of temperature.
To determine the per-residue contribution of SFG and Compound 5 to the total ΔG bind at the SAM-binding site, atomic level per-residue free energy decomposition was implemented for significant residues of each ligand using the AMBER14 MM/GBSA approach. The SFG-and Compound 5-bound complexes were subjected to further analysis.
| Dynamic cross-correlation
Dynamic Cross-Correlation (DCC) is a well-known approach that may be utilized in the interpretation of molecular dynamic simulation-derived trajectories, by quantifying the correlation coefficients of motions between atoms.
[ The DCC matrix produced from each simulated system was constructed using Origin software.
| Pharmacophore model generation and structure-based screening
The creation and analysis of a pharmacophore model is established as a vital part of drug design, as it is a beneficial tool for detection and development of new chemical entities (NCEs). [42] LigandScout [43] tool was used to generate a pharmacophore model from the simulation of SFG.
| RESULTS AND DISCUSSION
| Molecular dynamic simulations and systems stability
Trajectories of the Apo MTase system, as well as the SFGand Compound 5-bound MTase systems were monitored during a 200-ns simulation to confirm the systems' stability, together with the precision of ensuing postdynamic analyses.
| Deviation of α-carbons within
NS5 MTase
The stability of the 200-ns molecular dynamic simulations of the Apo MTase versus SFG-bound MTase versus Compound 5-bound MTase systems were explored by calculating the
RMSD. In Figure 5 , we demonstrate that during the simulation, the two inhibitor-bound complexes showed various RMSD patterns. The Compound 5-bound complex had reached convergence after 20 ns; however, the system began to fluctuate after 143 ns, although remaining within a 2.0 Å range until the end of the simulation. The SFG-MTase complex reached convergence after 169 ns, with fluctuations less than 1.5 Å. Indeed, both bound systems demonstrate stability; however, binding of SFG to the NS5 MTase renders the enzyme more stable than that of Compound 5, as convergence was maintained upon SFG-binding.
It was also noticed that binding of SFG to the MTase not only causes the SAM-binding site to become closed by the surround binding site loop (residues 100-110), but the MTase also conforms to close the RNA-binding site as the surrounding loop (residues 30-60) moves to prevent RNA from binding. Should RNA not bind to the MTase, replication off viral RNA by the RdRp will most likely not occur, preventing viral replication from occurring.
The fluctuation in rigidity in the Apo MTase (greater than 2 Å) prevented the system from reaching convergence, even toward the latter period of the simulation, indicating instability of the Apo MTase. These major rigorous fluctuations, as well as the fact that the bound systems had reached convergence while the unbound system had not, suggest that the MTase only stabilized upon binding of inhibitors, SFG and Compound 5.
| Atomic distribution of NS5
MTase backbone
The radius of gyration (RoG) is an indicator of a structure's stability during a molecular dynamic simulation, as is associated with the compactness of secondary protein structures into 3D structures. [44] To assess the conformations of the Apo MTase, SFG-and Compound 5-bound MTase complexes, RoG was analyzed and plotted (Supporting Information Figure S1 ). It was noticed that in the RMSD plot ( Figure 6 ), at 52, 122 and 173 ns the Apo MTase fluctuated significantly, while binding of both inhibitors, SFG and Compound 5, had stabilized the enzyme at those points in the simulation. Correspondingly, the RoG plots showed similar trends at 52, 122 and 173 ns, as both inhibitors caused the MTase to become more compact to accommodate binding. The Apo MTase had a greater atomic distribution than the inhibitorbound complexes and is therefore, more flexible and less compact than when bound.
| Intra-and intermolecular interactions in ZIKV NS5 MTase
| Intermolecular hydrogen bond patterns
Hydrogen bonding between amino acid residues is subject to the spatial arrangement of the associated atoms, and is a major driving force in structural changes that occur within proteins. To further analyze the forces that drive the conformational changes within the enzyme, we evaluated the hydrogen bonding pattern of the apo, SFG-bound and Compound 5-bound MTase systems throughout the simulation.
We present in Figure 6 very similar hydrogen bonding patterns between the SFG-bound and Compound 5-bound MTase complexes. The SFG-bound MTase exhibited a slightly lesser number of hydrogen bonds than the Compound 5-bound MTase, during 25-75 and 130-155 ns, which correspond with the flexibility of the protein during that period of the simulation. Nonetheless, toward the latter period of the simulation, i.e. between 170 and 200 ns, the number of hydrogen bonds was approximately consistent in both inhibitor-bound MTase complexes. Although, the apo MTase displayed a reduced number of hydrogen bonds than both inhibitor-bound complexes, indicating that the apo system was less stable than bound systems.
| Residual variations within the
NS5 MTase
To determine the flexibility of amino acid residues in the Apo and bound systems, root of mean square fluctuation (RMSF) of the residue α-carbons were calculated. In Figures 7 and 8 , we illustrate that the MTase is more flexible when unbound, as compared to SFG-and Compound 5-bound enzymes, respectively. Binding of SFG and Compound 5 lower the systems' energy fluctuations making them more stable.
Most binding site residues displayed resemblance in energy patterns in both inhibitor-bound and unbound conformations (binding site residues of SFG: Ser52, Gly54, Ser55, Asp75, Gly77, Cys78, Gly79, Gly82, Trp83, Tyr99, Thr100, Lys101, Gly102, His106, Glu107, Val126, Asp127, Va128, Phe129, Asp142, Ile143, and Lys178; binding site residues of Compound 5: Lys57, Gly77, Cys78, Gly79, Arg80, Gly81, Gly82, Thr100, Lys101, His106, Glu107, Asp127, Val128, Phe129, Asp142, Ile143, Gly144, Glu145, Ser146, Arg159, and Lys178), while others fluctuated significantly. Those binding site residues that altered in motion greatly throughout the simulation include 106 and 107 upon SFG binding, as well as 100, 101, 102, 127, 128, and 129 upon Compound 5 binding. An intriguing observation is that although the residues that form a loop at the binding site (residues 100-107) altered in conformation majorly throughout These results are concurrent to those of DCC, which was utilized in the analysis of fluctuations of atoms within the NS5 MTase backbone, as well as domain motions, focusing specifically on the α-carbons. Variations of colors represent residue distance analysis plots, where red to yellow areas signify positive/strong-correlated movements between α-carbons of residues and blue to black areas signify negative/anti-correlated movements. In Supporting Information Figure S2 , it can be noticed that the Apo MTase fluctuates more than when bound. It is evident that highly fluctuating residues that are shown in RMSF graphs are parallel to the anti-correlative residual movements in the DCC plots of each system. Likewise, residues that follow similar trends in movement throughout the simulation show strong correlation patterns.
| Binding free energy calculations
Average measures of the all factors of molecular mechanics computed over the 200-ns molecular dynamic simulation of the SFG-MTase and the Compound 5-MTase systems are tabulated in Table 1 .
The approximated binding free energy between SFG and the MTase is −34.99 kcal/mol, while that of Compound 5 and the MTase is −21.27 kcal/mol. This substantial difference in binding energy (~13 kcal/mol) between the individual inhibitors and the enzyme corresponds with experimental evidence that SFG binding to the MTase is potent at a lower IC 50 than that of Compound 5. [21] The estimated van der Waals contributions (ΔE vdW ) and electrostatic contributions 
| Decomposition analysis of binding site interaction energy
The binding free energy was decomposed further into contributions from specific amino acid residues of the MTase. We present via the graphs in Figures 9 and 10 the contrasting protein-ligand interaction continua between the SFG-bound MTase and the Compound 5-bound MTase, respectively. The per-residue energy decomposition analysis that we've presented in Figure 9 show that the highly contributing binding site amino acid residues toward the energy of the SFG- Figure 10 , it can be concluded that the electrostatic energy contribution from residues 107, 142, and 145, and the van der Waals energy from residues 106 and 143 in the Compound 5-MTase complex may be accountable for the high interaction energy in the system (ΔG bind = −21.27).
The large difference in binding affinity between the SFGbound and Compound 5-bound complexes (~13 kcal/mol) may be owing to the increase in electrostatic binding energy of Asp142 of the MTase to SFG, as well as van der Waals and electrostatic energies of His106, as compared to that of Compound 5.
| Fingerprints for the design of new chemical entities (NCEs)
Looking at the binding implications of SFG to the ZIKV NS5 MTase, potential use of SFG could be a promising starting point as a prototype candidate for ZIKV treatment. We therefore created a map depicting the key chemical, structural, and pharmacophoric fingerprints of SFG that will assist medicinal chemists and researchers in the identification and design of future new chemical entities for potential ZIKV inhibitors. The pharmacophoric elements that associate with highly contributing residues of the MTase were chosen to build our ensemble as we have illustrated in Figure 11 .
As we have presented in Figure 11 , it can be noticed that the N6 and N7 atoms are crucial to interact with the target by creating positive ionization with Glu107 and Asp142 of the ZIKV MTase, respectively. Retention of N6 and N7 will contribute positive ionizations responsible for ligandenzyme interactions. Furthermore, the N2, N5, O2, O3, and O5 atoms are essential in the formation of strong hydrogen bonds with Arg159, His106, Gly79, Thr100, Lys101, and Arg80, respectively, which are mandatory for enzyme stability. Preservation of the N2, N5, O2, O3, and O5 atoms will induce stability and strong binding of NCEs to the ZIKV MTase. 
| CONCLUSIONS
The ZIKV is a "public health emergency of international concern" and therefore a serious global threat. Apart from ZIKV, Compound 5 and SFG have also shown inhibitory effects in other flaviviruses, including DENV, WNV, YFV, and JEV. The molecular dynamic analyses described this study reveal the conformational evolutions, i.e. variations in the ZIKV NS5 MTase after binding of these inhibitors at a molecular level. Molecular dynamic simulations of 200 ns demonstrate radical movements within the MTase, particularly of the loops surrounding the SAM-binding pocket and RNA-binding site. The dynamic loop fluctuations in motion were uncovered in the RMSD and RMSF analyses and substantiated by examining the three-dimensional molecular landscape of the loops at specific time intervals throughout the simulation.
Upon binding to the MTase, both SFG and Compound 5 have shown to stabilize the rather erratic apo system, although, it was noticed that SFG renders the MTase more stable and more compact than Compound 5. The SFG-bound system also reached convergence while the Compound 5-bound system did not. The binding affinity and binding site interactions (bond and non-bond interactions) between SFG and the SAM-binding pocket of the MTase were stronger than those of Compound 5. Binding energy calculations identified His106, Glu107, Asp127, Asp142, and Ile143 as key players in the binding of SFG to the MTase; and Gly77, Thr100, His106, Glu107, Asp142, Glu145, and Lys178 in the binding of Compound 5 to the MTase.
Binding of SFG to the SAM-binding pocket caused the loop surrounding the pocket (residues 100-110) to shift so that SFG is held tighter in a more compact conformation. SFG-binding also resulted in the loop surrounding the RNA-binding site (residues 30-60) to cover the binding site, to prevent RNA from binding and replication from occurring. Strong and stable binding of SFG would also prevent SAM from binding and activating the MTase, avoiding methylation of RNA and the mRNA cap.
To explore the use of SFG as a potential starting point as a prototype candidate for ZIKV treatment, we created a pharmacophore of SFG that will assist medicinal chemists and researchers in the identification and design of future new chemical entities for potential ZIKV inhibitors.
The information interpreted in this study will improve the understanding of ZIKV and will be beneficial in driving the development of anti-ZIKV drugs. Further experimentation is required to elucidate the roles of SFG and Compound 5 in ZIKV treatment.
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